JT Group Sustainability Targets
-
Living with the Planet
-
Value Creation that Exceeds
Consumer Expectations -
Investing in our People and
Supporting their Growth -
Responsible Supply Chain
Management -
Good Governance
Materiality |
Target items |
Targets |
|
---|---|---|---|
Biodiversity impact assessment |
Each of the JT Group businesses will perform assessments to evaluate its impact and dependency on ecosystem, including biodiversity aspects. Impact assessments of our tobacco business will be performed by 2024, and our pharmaceutical and processed food business by 2025. |
||
Emissions reduction |
The JT Group will reduce its emissions and commits to be Carbon Neutral for its own operations by 2030 and achieve Net-Zero Greenhouse Gas emissions across its entire value chain by 2050.
|
||
Renewable energy |
By 2050, the JT Group will transition all of our energy use to zero carbon energy by 2050.
|
||
Protecting water |
The JT Group will engage in responsible water management and will pursue the following:
|
||
Enhancing biodiversity - No deforestation, no conversion |
With a view to enhancing biodiversity, the JT Group will contribute further to preserving forestry by pursuing the following in our tobacco business supply chain:
|
||
Waste reduction |
The JT Group will further reduce the environmental impacts of waste associated with its processes and products.
|
||
Designing for circularity - packaging, product and device |
The JT Group will reduce our packaging (including plastic) and ensure that the remaining is 88% reusable or recyclable by 2025, rising to 100% by 2030.
|
||
Sustainable agriculture |
Our tobacco business will complete the elimination of Criterion 1 Highly Hazardous Pesticides (HHPs) from its direct tobacco leaf supply chain in 2024 and eliminate the use of all HHPs by 2040. 100% of our directly-contracted growers will have adopted Good Agricultural Practices (GAP) Protocol of our tobacco business by 2030. |
Materiality |
Target items |
Targets |
|
---|---|---|---|
Reduced-Risk Products |
Our tobacco business will make its RRP* available in an increasing number of countries worldwide. |
||
Transparency in Reduced Risk Science |
In our tobacco business, we will ensure that reduced risk claims are substantiated and that we are transparent about the risks of our products. |
||
Youth Access Prevention (YAP) |
In our tobacco business, we will continue deliver training on YAP to our marketing and sales force. We will also continue to work with our trading partners to ensure compliance with its YAP pillars. |
||
Creating first-in-class drugs |
In our pharmaceutical business, we will continue our efforts and investments in research and development activities for innovative drugs in specific therapeutic areas. |
||
Food inclusion |
In our processed food business, we will be aware of the diversifying values and interests of our consumers. Most of all so that our consumers can enjoy delicious food, we will not only exclude certain raw materials, but also develop and provide high-value-added products, such as allergy-friendly products, products that do not use ingredients derived from animals, or products that are health-conscious and satisfy other preferences. |
*
RRP(Reduced-Risk Products): Products with the potential to reduce the risks associated with smoking
Materiality |
Target items |
Targets |
|
---|---|---|---|
Diversity, equity & inclusion |
Diversity in gender, nationality, individual experiences, expertise and values forms the foundation of a company’s success and contributes to real sustainable growth. We will promote initiatives to enhance diversity and promote inclusion. Furthermore, as part of our efforts to empower women, our Group target for women’s representation in managerial positions is to reach 30% by 2030.
|
||
Talent attraction |
We will work to retain and attract our people from each location or business to build a continuous pipeline of talents to lead and manage our business. Our tobacco business will aim at achieving yearly Global Top Employer certification. |
||
Attractive working conditions |
While working at the JT Group, our employees will go through various stages in life. We will strive to improve our system so that the career path and work-life balance desired by each person is realized. We will also encourage and monitor rates for parental leave, so that we can provide support to our employees in balancing work and family life. |
||
Health and safety |
We will prioritize the health and safety of our employees by proactively monitoring physical and mental health with the goal of achieving zero workplace injuries.
|
||
Development support |
We will create an ecosystem in which each JT Group employee can consider their own careers and make career choices. We will also provide learning opportunities tailored for each employee to proactively support their growth and the growth of our organization. |
||
Internal and external collaboration |
To promote collaborations within the Group across regions and functions, we will provide opportunities for collaborations while also proactively engage in collaborating with external parties to contribute to the development of inclusive and sustainable communities. Between 2015 and 2030, our employees will contribute 300,000 volunteering hours. |
Materiality |
Target items |
Targets |
|
---|---|---|---|
Supplier screening and supply chain due diligence |
The JT Group will screen all key suppliers against ESG criteria. Our tobacco business will screen 100% of its key suppliers against environmental, social and governance criteria by 2023. The tobacco business will also implement Agricultural Labor Practices (ALP) program in all leaf-sourcing countries by 2025. Furthermore, by 2025, our tobacco business will proactively manage ESG risks with all its critical suppliers, to ensure a sustainable business continuity. By 2028, all tobacco supplying entities will achieve a Supply Chain Due Diligence maturity score >90%, verified by an independent third party. By 2025, we will complete supply chain due diligence of all key suppliers for our pharmaceutical business and processed food business and will also perform regular due diligence thereafter. Through the JT Group Supplier Code of Conduct and supplier questionnaires, our processed food business will work jointly with, share its values and communicate closely with its suppliers to realize a sustainable supply chain. |
||
Grower living income |
In our tobacco business, the ambition is for all our leaf growers to achieve a living income. By 2025, we will implement our Living Income Calculator in 100% of our direct tobacco leaf supply chain origins. |
||
Human rights in grower communities |
By 2025, our tobacco business will monitor 100% of farms in its direct tobacco leaf supply chain origins on human rights including child labor, and annually disclose related KPIs, prevention and remediation actions. |
||
Grievance mechanisms |
By 2027, our tobacco business will provide access to remedy via safe, accessible and effective grievance mechanisms for 100% of growers and farm workers in its direct tobacco leaf supply chain origins. |
Materiality |
Target items |
Targets |
|
---|---|---|---|
|
Community investment |
Between 2015 and 2030 we will invest US$600 million to help make communities inclusive and resilient, with our employees contributing 300,000 volunteering hours. |
|
Internal control |
Our tobacco business will always protect its ability to participate in public policy debate with the aim to achieve balanced regulation that meets societal concern and support business growth. The tobacco business will also engage in dialogue with law enforcement agencies, with the goal to exchange intelligence regarding illegal tobacco products, in order to support the reduction of these products. In our pharmaceutical business, to develop talent and foster employees’ ethical awareness and sense of responsibility towards saving patients, we will continue to learn more about patients’ needs by engaging in dialogue with medical experts through our internal educational activity “For the Patients Project”. We will also conduct, among others, regular training programs for our medical representatives to provide medical professionals with latest, appropriate information on pharmaceutical products. Our processed food business will promote food safety management in compliance with global food safety standards to develop the highest level of food safety. While working on enforcing food safety and quality assurance, the processed food business will also enhance the way it communicates with consumers to provide them with safe, secure and high-quality products. |